Bumetanide
- Product NDC
- 25021-321
- 11-digit product format
- 250210321
- Labeler code
- 25021
- Product ID
- 25021-321_befc1cf3-b71c-4228-bc42-3495b1d4b00d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bumetanide
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA074441
- Marketing category
- ANDA
- Marketing start
- 2024-06-01
- Substance
- BUMETANIDE
- Active strength
- .25 mg/mL
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0Y2S3XUQ5H | BUMETANIDE | 28395-03-1 | BUMETANIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 25021-321-04 | 25021032104 | 10 VIAL in 1 CARTON (25021-321-04) / 4 mL in 1 VIAL | 10 vial | 2024-06-01 | No | No | Historical |
| 25021-321-10 | 25021032110 | 10 VIAL in 1 CARTON (25021-321-10) / 10 mL in 1 VIAL | 10 vial | 2024-06-01 | No | No | Historical |